03/11
Moderna (MRNA) is a 8 billion bio tech company that has development of transformative medicines based on messenger ribonucleic acid (mRNA).
Comparing to traditional DNA-based drug development, mRNA is much faster in development. Global fighting with Corona virus gives Moderna a chance to show its power.
Long term holding (more than 3 months) is recommended for maximum profit.